[go: up one dir, main page]

IN2014MU00675A - - Google Patents

Download PDF

Info

Publication number
IN2014MU00675A
IN2014MU00675A IN675MU2014A IN2014MU00675A IN 2014MU00675 A IN2014MU00675 A IN 2014MU00675A IN 675MU2014 A IN675MU2014 A IN 675MU2014A IN 2014MU00675 A IN2014MU00675 A IN 2014MU00675A
Authority
IN
India
Prior art keywords
preparation
relates
present
dabigatran etexilate
acid addition
Prior art date
Application number
Inventor
Vijayavitthal Thippannachar Mathad
Pavankumar Vrajlal Solanki
Sekhar Babu Uppelli
Ganesh Gitaram Sarode
Original Assignee
Megafine Pharma P Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megafine Pharma P Ltd filed Critical Megafine Pharma P Ltd
Priority to PCT/IN2015/000100 priority Critical patent/WO2015128875A2/en
Priority to IN675MU2014 priority patent/IN2014MU00675A/en
Publication of IN2014MU00675A publication Critical patent/IN2014MU00675A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an improved process for the preparation of Dabigatran etexilate and its acid addition salts thereof, wherein the said process substantially eliminates the potential impurities. The present invention also relates to an intermediate of Dabigatran etexilate and process for preparation thereof
IN675MU2014 2014-02-26 2015-02-23 IN2014MU00675A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IN2015/000100 WO2015128875A2 (en) 2014-02-26 2015-02-23 A process for preparation of dabigatran etexilate mesylate and intermediates thereof
IN675MU2014 IN2014MU00675A (en) 2014-02-26 2015-02-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN675MU2014 IN2014MU00675A (en) 2014-02-26 2015-02-23

Publications (1)

Publication Number Publication Date
IN2014MU00675A true IN2014MU00675A (en) 2015-10-23

Family

ID=53267425

Family Applications (1)

Application Number Title Priority Date Filing Date
IN675MU2014 IN2014MU00675A (en) 2014-02-26 2015-02-23

Country Status (2)

Country Link
IN (1) IN2014MU00675A (en)
WO (1) WO2015128875A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105732433A (en) * 2016-04-13 2016-07-06 山东新华制药股份有限公司 Refining method of Dabigatran etexilate intermediate condensation compound
CN110878083A (en) * 2018-09-05 2020-03-13 连云港恒运药业有限公司 Purification method of dabigatran etexilate intermediate
CN111690699A (en) * 2020-05-19 2020-09-22 浙江工业大学 Method for enzymatic on-line synthesis of 3- (pyridine-2-amino) propylhydroxamic acid
CN114113346B (en) * 2020-08-25 2024-01-12 石药集团恩必普药业有限公司 Detection method of ethyl p-toluenesulfonate and isopropyl p-toluenesulfonate in dabigatran etexilate bulk drug or preparation
CN114716411B (en) * 2022-04-29 2024-03-15 天方药业有限公司 Method for recovering and preparing dabigatran etexilate mesylate from production mother liquor
CN115417855A (en) * 2022-09-22 2022-12-02 安徽美诺华药物化学有限公司 Synthesis process of dabigatran etexilate mesylate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE121699A1 (en) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma BICYCLE HETERO CYCLES DISSTITUTED AS INHIBITORS OF THROMBIN
US20050107409A1 (en) * 2003-03-10 2005-05-19 Boehringer Ingelheim International Gmbh Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions
DE10339862A1 (en) 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg New crystalline forms of ethyl 3-(N-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-N-(2-pyridyl)amino)propionate methanesulfonate used for post-operative prophylaxis of deep vein thrombosis
EP1609784A1 (en) 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Process for the preparation of 4-(benzimidazolylmethylamino)-benzamidines
DE102005025728A1 (en) 2005-06-04 2006-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Polymorphs of 3 - [(2 - {[4- (hexyloxycarbonylamino-imino-methyl) -phenyl-amino] -methyl} -1-methyl-1H-benzimidazole-5-carbonyl) -pyridin-2-yl-amino] -propionic acid ethyl ester
ITTO20050486A1 (en) 2005-07-14 2005-10-13 Dumitru Bucuresteanu AIR OPERATING COMPRESSOR WITH CONTINUOUS PROPELLER IN A TURNTABLE TUBE
DE102006054005A1 (en) 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg New polymorphs of 3 - [(2 - {[4- (hexyloxycarbonylamino-imino-methyl) -phenyl-amino] -methyl} -1-methyl-1H-benzimidazole-5-carbonyl) -pyridin-2-yl-amino] -propionic acid ethyl
CZ305085B6 (en) * 2008-03-14 2015-04-29 Zentiva, K.S. Process for preparing dabigatran
CZ2008669A3 (en) 2008-10-24 2010-05-05 Zentiva, A. S. Process for preparing dabigatran and intermediates thereof
HUP1100244A2 (en) 2011-05-11 2012-11-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Pharmaceutical intermediates and process for their production
EP2522662A1 (en) 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers

Also Published As

Publication number Publication date
WO2015128875A3 (en) 2015-11-12
WO2015128875A2 (en) 2015-09-03

Similar Documents

Publication Publication Date Title
LT3204015T (en) COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF HAO1 (HYDROXIC ACID OXIDASE 1 (GLYCOLATE OXIDASE))
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
MX388170B (en) SELINEXOR POLYMORPHS
IN2014CH00247A (en)
IN2013MU00646A (en)
WO2014192030A3 (en) An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof
IN2014MU00675A (en)
IN2014MU00455A (en)
MX377271B (en) PREPARATION OF RED IRON OXIDE PIGMENTS.
PH12016501613B1 (en) Pyrazines modulators of gpr6
IN2014CH00840A (en)
IN2013MU01113A (en)
MX2019004182A (en) Process for the manufacture of 2,6-dimethyl-5-hepten-1-al.
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
IN2014CH00304A (en)
EA201692246A1 (en) Method of producing 2,6-dimethylbenzoquinone
IN2013MU01290A (en)
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
IL250260A0 (en) Process for the preparation of 4,5,6-trichloropicolinic acid
IN2013CH05865A (en)
MY173051A (en) Microorganism having producing ability of quinolinic acid and method for producing quinolinic acid using the microorganism
IN2014CH01391A (en)
MX361888B (en) An improved process for making zilpaterol.